Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
BMY Reports Net Sales Fell 18% to $4.4 Billion

Bristol-Myers Squibb Financials Reported

July 25, 2012

On July 25, 2012, Bristol-Myers Squibb Company (NYSE: BMY) reported results for the second quarter of 2012.

To view the full article, please subscribe or login.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked #1 for 15-Yr. Annualized Returns: Turnaround Letter's 13.2% vs. S&P's 2.2%
  • 28+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

Distressed Investing Blog

Distressed Investing Blog

Looking for a Year-End Bounce: Stock Profit from Artificial Selling Pressures

Looking to cash in on timely tax loss selling and portfolio window dressing? These 10 year-end bounce stock picks represent the worst performers in the S&P 500 during calendar 2014, adjusted somewhat so that there is good diversification by industry group. Read More.

Sample Issue

TL Spotlight

George Putnam has always followed the same straight-forward and highly-profitable investment philosophy. He published his first Turnaround Letter issue back in 1986, and readers have seen extraordinary long-term stock profit ever since.

 

In fact, 12 of 2014's 13 closed-out purchase recommendations saw gains--with five of those enjoying total returns greater than 100%. The Turnaround Letter's average return for 2014's stock picks is +82%:

 

2014 Closed Out Purchase Recommendations

Value Stock Picks

* Calculation includes dividends and price changes between purchase recommendation and current price.

 

Learn more.